Advances in Molecular Oncology
"Advances in molecular oncology" — is a quarterly peer-reviewed journal of research and practice. It was founded in 2014.
Editor-in-chief — Ph.D., Professor, Deputy Director for Science N.N. Blokhin National Medical Research Oncology Center, Ministry of Health of Russia - the director of Institute of Carcinogenesis — Krasilnikov Mikhail Alexandrovich.
The journal is put on the Higher Attestation Commission list of periodicals (the list of leading peer-reviewed scientific journals recommended to publish the basic research results of doctor’s and candidate’s theses). Since 2014, the journal was included in the Research Electronic Library and the Russian Science Citation Index (RSCI) and has an impact factor.
In 2015, the journal has been registered with CrossRef; its papers are indexed with the digital object identifier (DOI).
In September 2020, the decision was made to include the journal in the Scopus database.
Target audience: oncologists, molecular biologists, geneticists, biochemists, virologists, cancer epidemiologists, chemotherapists.
Information content: reviews, mini-reviews, brief communications and full-size research articles, comments of leading experts. Editorial board members and authors of the journal are the leading Russian and foreign oncologists, molecular biologists, geneticists, chemotherapists and specialists of related professions.
Frequency: 4 issues per year
Format: A4.
Page contents: from 72 to100 pages.
Circulation: 1000 copies.
Distribution: address in the Russian Federation and CIS countries.
Index of subscription: "Press of Russia" catalogue – 93562.
Anyone can subscribe to the Journal in the site of the «ABV-press» Publishing house.
Information about types of advertising in the printed publications can be found in «Cooperate» section.
Current Issue
Vol 12, No 4S (2025): Supplement
- Year: 2025
- Published: 05.12.2025
- Articles: 0
- URL: https://umo.abvpress.ru/jour/issue/view/53
-
Description:
Materials
of the 10th Jubilee Russian Conference on Molecular Oncology
Moscow, 29–31 October 2025

